Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 17/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14215745 | 0.92 | NR1H4 (0.40) | NR1H4CYP1A2CYP2C9ALDH1A1MAPT | |
| SCHEMBL14215700 | 0.88 | NR1H4 (0.43) | NR1H4CYP1A2CYP2C9MCL1 | |
| SCHEMBL14215702 | 0.84 | NR1H4 (0.44) | NR1H4CYP1A2CYP2C9ALDH1A1MAPT | |
| SCHEMBL14215901 | 0.83 | NR1H4 (0.39) | NR1H4L3MBTL1 | |
| SCHEMBL14215746 | 0.82 | NR1H4 (0.51) | NR1H4CYP1A2CYP2C9 | |
| SCHEMBL14215747 | 0.82 | NR1H4 (0.51) | NR1H4CYP1A2CYP2C9 | |
| SCHEMBL14215781 | 0.78 | MAPT (0.39) | NR1H4CYP1A2CYP2C9ALDH1A1MAPT | |
| SCHEMBL14215701 | 0.76 | ALDH1A1 (0.37) | NR1H4CYP1A2CYP2C9ALDH1A1MAPT | |
| SCHEMBL14215804 | 0.76 | NR1H4 (0.41) | NR1H4CYP1A2CYP2C9MCL1 | |
| SCHEMBL2002481 | 0.75 | NR1H4 (0.68) | NR1H4CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008051942-A2 | FARNESOID X RECEPTOR AGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-05-02 | — | — | WO | disclosed |